Metraipolis › archive › dc_507515fd3912

Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial — Europe PMC PMID:41776515

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41776515
DOI: 10.1186/s12916-[numero omesso]-3
License (as archived): solo-consultazione
Archived: 2026-11-05T03:56:18.767Z
SHA-256 of the archived text: dc6912ce0897e40aed5ebdd991ce1c4f65cda029ddbb5790c3c05e1bd86e25af
Stable URL of this page: https://metraipolis.com/documento/dc_507515fd3912

How to cite

Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial — Europe PMC PMID:41776515 — Europe PMC (en), https://europepmc.org/article/MED/41776515 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_507515fd3912 (Metraipolis archive dc_507515fd3912, sha256 dc6912ce0897e40aed5ebdd991ce1c4f65cda029ddbb5790c3c05e1bd86e25af)

BibTeX

@misc{dc507515fd3912,
  title = {Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial — Europe PMC PMID:41776515},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41776515},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_507515fd3912; sha256 dc6912ce0897e40aed5ebdd991ce1c4f65cda029ddbb5790c3c05e1bd86e25af},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41776515. Agents can read the archived copy with the MCP tool read_document.